Premium
FDA permits marketing of mobile medical application for substance use disorder
Publication year - 2017
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30251
Subject(s) - substance use , food and drug administration , stimulant , advertising , psychiatry , citation , medicine , psychology , computer science , library science , medical emergency , business
Last month, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorder (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana, and stimulant SUDs. The application is not intended to be used to treat opioid dependence.